Christopher J. Tovey is EVP, COO & Managing Director E of Jazz Pharmaceuticals plc. Currently has a direct ownership of 14,663 shares of JAZZ, which is worth approximately $1.61 Million. The most recent transaction as insider was on Jul 05, 2022, when has been sold 5,209 shares (Ordinary Shares) at a price of $160.0 per share, resulting in proceeds of $833,440. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.7K
0% 3M change
0% 12M change
Total Value Held $1.61 Million

Christopher J. Tovey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 05 2022
SELL
Open market or private sale
$833,440 $160.0 p/Share
5,209 Reduced 26.21%
14,663 Ordinary Shares
Jul 05 2022
BUY
Exercise of conversion of derivative security
$81 $0.02 p/Share
4,032 Added 16.87%
19,872 Ordinary Shares
May 05 2022
SELL
Payment of exercise price or tax liability
$167,929 $153.22 p/Share
1,096 Reduced 6.47%
15,840 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
7,820 Added 31.59%
16,936 Ordinary Shares
May 05 2021
BUY
Grant, award, or other acquisition
-
9,091 Added 49.93%
9,116 Ordinary Shares
CJT

Christopher J. Tovey

EVP, COO & Managing Director E
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ